Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

LXRX

Lexicon Pharmaceuticals Inc

Apr 18 • 04:00PM ET

1.63

Dollar change +0.01
Percentage change 0.62	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF IWM SCHA VTWO IWN IWO ITOT IWC VFMO

Index	RUT	P/E	-	EPS (ttm)	-0.79	Insider Own	2.72%	Shs Outstand	244.92M	Perf Week	-19.70%
Market Cap	401.37M	Forward P/E	-	EPS next Y	-0.66	Insider Trans	1.52%	Shs Float	239.55M	Perf Month	-33.20%
Income	-175.61M	PEG	-	EPS next Q	-0.20	Inst Own	26.65%	Short Float	9.15%	Perf Quarter	25.38%
Sales	1.21M	P/S	331.71	EPS this Y	10.13%	Inst Trans	18.05%	Short Ratio	4.56	Perf Half Y	30.40%
Book/sh	0.38	P/B	4.29	EPS next Y	7.51%	ROA	-82.89%	Short Interest	21.91M	Perf Year	-37.31%
Cash/sh	0.69	P/C	2.36	EPS next 5Y	-	ROE	-167.06%	52W Range	0.92 - 3.79	Perf YTD	6.54%
Dividend Est.	-	P/FCF	-	EPS past 5Y	6.80%	ROI	-88.74%	52W High	-56.98%	Beta	1.37
Dividend TTM	-	Quick Ratio	5.58	Sales past 5Y	186.21%	Gross Margin	46.97%	52W Low	77.17%	ATR (14)	0.17
Dividend Ex-Date	-	Current Ratio	5.60	EPS Y/Y TTM	-28.28%	Oper. Margin	-14253.11%	RSI (14)	31.88	Volatility	7.68% 8.03%
Employees	285	Debt/Eq	1.14	Sales Y/Y TTM	766.91%	Profit Margin	-14573.20%	Recom	2.33	Target Price	6.25
Option/Short	Yes / Yes	LT Debt/Eq	1.13	EPS Q/Q	-21.91%	Payout	-	Rel Volume	0.77	Prev Close	1.62
Sales Surprise	-43.88%	EPS Surprise	7.92%	Sales Q/Q	2407.14%	Earnings	Mar 11 BMO	Avg Volume	4.81M	Price	1.63
SMA20	-22.13%	SMA50	-31.12%	SMA200	-4.82%	Trades		Volume	3,713,440	Change	0.62%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-07-23	Initiated	Jefferies	Hold	$3
Aug-12-22	Initiated	Piper Sandler	Overweight	$10
Jan-29-21	Upgrade	JP Morgan	Underweight → Neutral	$7
Jan-29-21	Downgrade	Wedbush	Outperform → Neutral	$2 → $8
Dec-08-20	Upgrade	Citigroup	Neutral → Buy
Nov-18-20	Upgrade	Gabelli & Co	Hold → Buy
Dec-11-19	Downgrade	Gabelli & Co	Buy → Hold
Nov-08-19	Downgrade	Citigroup	Buy → Neutral	$3 → $4
Sep-11-19	Upgrade	Gabelli & Co	Hold → Buy	$3
Jul-29-19	Downgrade	Stifel	Buy → Hold	$10 → $4
Mar-25-19	Upgrade	Gabelli & Co	Sell → Hold
Jul-31-18	Reiterated	Stifel	Buy	$24 → $23
Feb-23-18	Downgrade	Needham	Buy → Hold
Feb-14-18	Downgrade	JP Morgan	Neutral → Underweight	$10
Mar-01-17	Reiterated	Wedbush	Outperform	$33 → $38
Mar-01-17	Reiterated	H.C. Wainwright	Buy	$26 → $27
Oct-07-16	Initiated	H.C. Wainwright	Buy	$26
Aug-05-16	Reiterated	Wedbush	Outperform	$30 → $31
Aug-02-16	Initiated	Citigroup	Buy	$21
Mar-02-16	Reiterated	Wedbush	Outperform	$26 → $28

Show Previous Ratings

Apr-18-24 08:00AM	Lexicon Pharmaceuticals to Host 2024 Investor Day (GlobeNewswire)
Apr-16-24 12:00PM	All You Need to Know About Lexicon (LXRX) Rating Upgrade to Buy (Zacks) -9.36%
Apr-03-24 08:00AM	Lexicon Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire) -7.69%
Mar-25-24 09:20AM	Clinical Data on the Impact of Sotagliflozin on Stroke and Heart Attack Risk Among Four Lexicon-Sponsored Presentations at the American College of Cardiology 73rd Annual Scientific Session & Expo (GlobeNewswire) -6.19%
Mar-13-24 12:45PM	Lexicon (LXRX) Dips on Post Hoc Analysis Data on Sotagliflozin (Zacks)
08:00AM	Loading…
Mar-12-24 08:00AM	New Post Hoc Analysis of inTandem3 Study Demonstrates Improvements In Glycemic Control With Sotagliflozin Treatment in Patients With Type 1 Diabetes and Chronic Kidney Disease (GlobeNewswire) -10.32%
Mar-11-24 08:25AM	Lexicon Pharmaceuticals (LXRX) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +29.49%
07:34AM	Lexicon: Q4 Earnings Snapshot (Associated Press Finance)
07:15AM	Lexicon Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
07:05AM	Lexicon Announces Oversubscribed $250 Million Private Placement of Equity Securities (GlobeNewswire)
07:00AM	Lexicon Preparing to Resubmit Sotagliflozin NDA for Type 1 Diabetes Following Feedback From FDA (GlobeNewswire)
Feb-29-24 10:00AM	Analysts Estimate Lexicon Pharmaceuticals (LXRX) to Report a Decline in Earnings: What to Look Out for (Zacks)
Feb-22-24 12:58PM	15 Hot Penny Stocks On the Move (Insider Monkey) -5.58%
Jan-31-24 05:06AM	3 Under-the-Radar Stocks With 340% to 762% Upside in 2024, According to Select Wall Street Analysts (Motley Fool) +6.25%
Jan-23-24 05:21AM	3 of the Fastest-Growing Stocks on the Planet in 2024 (Motley Fool) +15.94%
07:00AM	Loading…
Jan-08-24 07:00AM	Lexicon Pharmaceuticals Provides Business and Pipeline Update at 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-26-23 05:06AM	3 Growth Stocks Expected to Skyrocket in 2024, According to Wall Street (Motley Fool) +7.63%
Dec-21-23 04:15PM	Lexicon Pharmaceuticals To Participate In The 42nd Annual JPMorgan Healthcare Conference (GlobeNewswire)
Nov-30-23 07:30AM	Lexicon Enrolls First Patient in Phase 2b Progress Study of LX9211 in Diabetic Peripheral Neuropathic Pain (DPNP) (GlobeNewswire)
Nov-22-23 07:30AM	Lexicon Pharmaceuticals to Participate in the 35th Annual Piper Sandler Healthcare Conference and the 6th Annual Evercore ISI HealthCONx Conference (GlobeNewswire)
Nov-15-23 01:03AM	Director Philippe Amouyal's Strategic 200,000 Share Purchase in Lexicon Pharmaceuticals Inc (GuruFocus.com)
Nov-12-23 02:10PM	INPEFA (sotagliflozin) Use Associated With Early Clinical Benefit in Heart Failure and Atherosclerotic Events in Analysis of Clinical Data (GlobeNewswire)
Nov-10-23 04:01PM	Lexicon Pharmaceuticals to Participate in the Jefferies London Healthcare Conference (GlobeNewswire)
10:53AM	Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-08-23 09:45PM	Q3 2023 Lexicon Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) -8.80%
07:19AM	Lexicon: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	Lexicon Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Nov-03-23 09:00AM	Lexicon Pharmaceuticals to Host Third Quarter 2023 Financial Results Conference Call and Webcast on November 8, 2023 (GlobeNewswire) +5.71%
Nov-02-23 09:00AM	Data on Early Clinical Benefit for INPEFA (Sotagliflozin) Will Be Among Five Lexicon-Sponsored Presentations at the American Heart Association Scientific Sessions 2023 (GlobeNewswire)
Nov-01-23 09:00AM	INPEFA (Sotagliflozin) Receives Coverage From Express Scripts on Its Basic and High Performance Formularies for Commercially Insured Patients (GlobeNewswire) +8.06%
04:01PM	Loading…
Oct-31-23 04:01PM	Lexicon Strengthens Management Team With Two New Executives (GlobeNewswire)
Oct-30-23 04:01PM	New Data Relating to Sotagliflozin to be Presented at the American Society of Nephrology (ASN) Kidney Week 2023 Annual Meeting (GlobeNewswire) +8.11%
Oct-25-23 08:45AM	Global Diabetes Care Market Size Expected To Reach $41.71 Billion By 2027 (PR Newswire)
Oct-17-23 04:01PM	Data From Two Studies Demonstrating Positive Financial Impact of INPEFA (Sotagliflozin) to be Presented at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023 National Meeting (GlobeNewswire) -8.09%
01:35PM	Hedge Fund and Insider Trading News: John Paulson, Ray Dalio, Starboard Value, Trian Fund Management, ExodusPoint Capital Management, JAT Capital, Lexicon Pharmaceuticals, Inc. (LXRX), Omnicom Group Inc. (OMC), and More (Insider Monkey)
Oct-13-23 11:38AM	Hedge Fund and Insider Trading News: Leon Cooperman, Ray Dalio, Bill Ackman, John Paulson, Altana Wealth Ltd., Apple Inc. (AAPL), Lexicon Pharmaceuticals Inc (LXRX), and More (Insider Monkey) +14.42%
Oct-11-23 11:13AM	Lexicon's (LXRX) Inpefa Gets Preferred Status at Express Scripts (Zacks)
09:00AM	Data Demonstrating Financial Impact of INPEFA (Sotagliflozin) to be Presented at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023 National Meeting (GlobeNewswire)
Oct-10-23 11:25AM	Why Shares of Lexicon Pharmaceuticals Are Up Tuesday (Motley Fool) +12.00%
09:44AM	Midday movers: PepsiCo, Unity, Rivian Automotive and more (Investing.com)
03:33AM	Lexicon Pharma shares rise after Inpefa gets preferred status at Express Scripts (Investing.com)
Oct-09-23 04:01PM	INPEFA (Sotagliflozin) Receives Preferred Formulary Status With Express Scripts For Medicare Patients (GlobeNewswire) -7.41%
08:00AM	Tom Garner Joins Lexicon as Senior Vice President and Chief Commercial Officer (GlobeNewswire)
Sep-28-23 09:00AM	Lexicon to Present Post Hoc Analysis of Scored Clinical Trial at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2023 (GlobeNewswire) -9.09%
Sep-26-23 09:00AM	Lexicon to Present Study Results Relating to Sotagliflozin and LX9211 at the 59th Annual Meeting of the European Association for the Study of Diabetes (EASD) (GlobeNewswire) +10.38%
Sep-20-23 12:28PM	15 Best Affordable Stocks To Buy Under $5 (Insider Monkey)
Sep-14-23 09:40PM	Insider Buying: Jeffrey Wade Acquires 10,000 Shares of Lexicon Pharmaceuticals Inc (LXRX) (GuruFocus.com)
Sep-07-23 04:30PM	Lexicon Pharmaceuticals to Participate in the H.C. Wainwright & Co. 25th Annual Global Investment Conference (GlobeNewswire)
09:00AM	Lexicon Announces Series of Presentations Relating to LX9211, Its Investigational Drug for the Treatment of Diabetic Peripheral Neuropathic Pain (DPNP) (GlobeNewswire)
Aug-21-23 09:00AM	Lexicon to Present Analyses of INPEFA (sotagliflozin) Clinical Study Results and Changing Patterns of Heart Failure Diagnoses at the European Society of Cardiology (ESC) Congress 2023 (GlobeNewswire)
Aug-17-23 09:56AM	10 Healthcare Stocks with Insider Buying (Insider Monkey)
Aug-08-23 09:00AM	Published Analysis of Sotagliflozin (INPEFA(TM)) Clinical Data Demonstrates Significant Reductions in the Risk of Hospital Readmissions for Heart Failure (GlobeNewswire) +7.06%
Aug-04-23 09:12AM	Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) stock most popular amongst private equity firms who own 49%, while individual investors hold 25% (Simply Wall St.)
Aug-03-23 05:15PM	Lexicon Pharmaceuticals (LXRX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:10PM	Lexicon: Q2 Earnings Snapshot (AP Finance)
04:01PM	Lexicon Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Jul-28-23 04:01PM	Lexicon Pharmaceuticals to Host Second Quarter 2023 Financial Results Conference Call and Webcast on August 3, 2023 (GlobeNewswire)
08:00AM	Lexicon Elects Diane E. Sullivan to Board of Directors (GlobeNewswire)
Jun-30-23 06:52AM	Daily Vickers Top Buyers & Sellers for 06/30/2023 (Argus Research) +5.53%
Jun-27-23 06:46AM	Daily Vickers Top Buyers & Sellers for 06/27/2023 (Argus Research)
Jun-23-23 08:45PM	Lexicon Announces Planned Advancement of LX9211 Into Late-Stage Development (GlobeNewswire)
09:24AM	Daily Vickers Top Buyers & Sellers for 06/23/2023 (Argus Research)
Jun-20-23 08:00AM	Lexicon to Present Study Results Relating to LX9211 and INPEFA (Sotagliflozin) at the American Diabetes Associations 83rd Scientific Sessions (GlobeNewswire)
Jun-15-23 05:00PM	UPDATE: Lexicon Announces FDA Approval of INPEFA (sotagliflozin) for Treatment of Heart Failure (GlobeNewswire)
Jun-06-23 04:01PM	Lexicon Pharmaceuticals to Participate in the Jefferies 2023 Global Healthcare Conference (GlobeNewswire)
Jun-05-23 04:01PM	Lexicon Announces Closing of Public Offering and Concurrent Private Placement, Including Full Exercise of Options to Purchase Additional Shares (GlobeNewswire) -7.47%
Jun-04-23 07:00AM	The Word Is, 'Lexicon' Is Worth a Trade (TheStreet.com)
Jun-02-23 09:21AM	Why Lexicon Pharmaceuticals Stock Crashed This Week (Motley Fool)
Jun-01-23 11:35AM	Biotech Stock Roundup: MRTX Falls on Study Failure, LXRX Drug Wins Approval & More (Zacks) -17.88%
08:00AM	Lexicon Announces Pricing of $125 Million Public Offering and Concurrent Private Placement (GlobeNewswire)
May-31-23 04:01PM	Lexicon Announces Proposed Public Offering of Common Stock (GlobeNewswire) +13.79%
May-26-23 04:25PM	UPDATE 2-U.S. FDA approves Lexicon Pharma's drug for heart failure (Reuters) +9.66%
04:08PM	U.S. FDA approves Lexicon Pharma's heart failure drug (Reuters)
04:05PM	Lexicon Announces FDA Approval of INPEFA (sotagliflozin) for Treatment of Heart Failure (GlobeNewswire)
May-22-23 07:33AM	Weekly biotech pulse: Sana, aTyr, Theseus to release fresh data (Investing.com) +6.64%
May-11-23 06:50AM	Wall Street's Counting on an FDA Nod for This Growth Stock to Nearly Double, but Should You? (Motley Fool)
May-10-23 04:30PM	New Analysis Finds Sotagliflozin to Be a Cost-Effective Treatment at Commonly Accepted Willingness-to-Pay Threshold in Patients with Worsening Heart Failure (GlobeNewswire)
May-04-23 10:05AM	Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q1 2023 Earnings Call Transcript (Insider Monkey) +12.41%
May-03-23 11:45AM	Q1 2023 Lexicon Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) +15.13%
May-02-23 04:00PM	Lexicon Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Apr-28-23 04:00PM	Lexicon Pharmaceuticals to Host First Quarter 2023 Financial Results Conference Call and Webcast on May 2, 2023 (GlobeNewswire)
Apr-22-23 08:15AM	Should You Buy This Growth Stock Right Now Before It Potentially Doubles? (Motley Fool)
Apr-21-23 09:00AM	Lexicon To Present Results From LX9211 Phase 2 Trial In Postherpetic Neuralgia At The 2023 American Academy Of Neurology (AAN) Annual Meeting And The British Pain Society (BPS) 56th Annual Scientific Meeting 2023 (GlobeNewswire)
Apr-17-23 04:00PM	Lexicon Pharmaceuticals to Participate in The 22nd Annual Needham Virtual Healthcare Conference (GlobeNewswire) +11.62%
Mar-06-23 06:00AM	Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-04-23 12:00PM	New Analyses of Sotagliflozin Showing Time to Clinical Benefit Presented at The American College of Cardiologys 72nd Annual Scientific Session Together With World Heart Federations World Congress of Cardiology (GlobeNewswire)
10:00AM	Lexicon Reveals INTO THE DARK Awareness Campaign About Vulnerable and Dangerous Period of Time Faced by Heart Failure Patients Following Hospitalization (GlobeNewswire)
Mar-03-23 07:07AM	Q4 2022 Lexicon Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) +22.94%
Mar-02-23 04:00PM	Lexicon Pharmaceuticals Reports Fourth Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Feb-28-23 05:00PM	Lexicon Pharmaceuticals to Host Fourth Quarter 2022 Financial Results Conference Call and Webcast on March 2, 2023 (GlobeNewswire)
Feb-20-23 08:00AM	New Analyses of Sotagliflozin to Be Presented at the American College of Cardiologys 72nd Annual Scientific Session Together With World Heart Federations World Congress of Cardiology (GlobeNewswire)
Feb-01-23 07:56AM	Lexicon Pharmaceuticals, Inc.'s (NASDAQ:LXRX) largest shareholders are private equity firms with 48% ownership, institutions own 26% (Simply Wall St.)
Jan-06-23 04:05PM	Lexicon Pharmaceuticals to Participate in the 41st Annual JP Morgan Healthcare Conference (GlobeNewswire)
Dec-29-22 06:52PM	Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q3 2022 Earnings Call Transcript (Insider Monkey) +7.22%
Dec-22-22 09:22AM	Lexicon Pharma's Pain Candidate Fails In Postherpetic Neuralgia Study (Benzinga)
Dec-21-22 04:30PM	Lexicon Announces Topline Results From Phase 2 Proof-of-Concept Study of LX9211 in Postherpetic Neuralgia (GlobeNewswire)
Nov-28-22 08:00AM	Lexicon Pharmaceuticals to Participate in the 34th Annual Piper Sandler Healthcare Conference and the 5th Annual Evercore ISI HealthCONx Conference (GlobeNewswire) -5.16%
Nov-15-22 10:00AM	Lexicon's Experimental Drug Shows Significant, Consistent Benefits In Diabetic Neuropathy Study (Benzinga)
Nov-14-22 04:03PM	Lexicons LX9211 Shows Significant and Consistent Benefits in the Treatment of Painful Diabetic Neuropathy in Full Results From the Phase 2 RELIEF-DPN-1 Trial Presented at the 16th Annual Pain Therapeutics Summit (GlobeNewswire)
Nov-12-22 07:28AM	Lexicon Pharmaceuticals Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag (Simply Wall St.)

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain, and Sotagliflozin, a treatment for heart failure and type 1 diabetes. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
COATS LONNEL	Chief Executive Officer	Nov 16 '23	Buy	1.05	90,000	94,797	914,359	Nov 17 04:55 PM
COATS LONNEL	Chief Executive Officer	Nov 10 '23	Buy	1.01	10,000	10,100	824,359	Nov 13 05:31 PM
DEBBANE RAYMOND	Director	Oct 12 '23	Buy	1.03	148,820	153,805	1,340,847	Oct 12 04:01 PM
DEBBANE RAYMOND	Director	Oct 11 '23	Buy	1.08	342,874	370,784	1,192,027	Oct 12 04:01 PM
DEBBANE RAYMOND	Director	Oct 10 '23	Buy	1.14	508,306	579,367	849,153	Oct 12 04:01 PM
WADE JEFFREY L	President and CFO	Sep 14 '23	Buy	1.38	10,000	13,800	264,341	Sep 14 05:05 PM
McDermott Wendy	VP, Human Resources	Aug 04 '23	Buy	1.84	6,000	11,040	28,478	Aug 07 04:13 PM
COATS LONNEL	Chief Executive Officer	Jun 29 '23	Buy	2.16	10,000	21,600	814,359	Jun 29 04:13 PM
COATS LONNEL	Chief Executive Officer	Jun 26 '23	Buy	2.18	10,000	21,792	804,359	Jun 26 04:04 PM
COATS LONNEL	Chief Executive Officer	Jun 23 '23	Buy	2.50	10,000	24,950	794,359	Jun 26 04:04 PM
McDermott Wendy	VP, Human Resources	Jun 23 '23	Buy	2.43	10,000	24,300	22,478	Jun 27 04:22 PM
COATS LONNEL	Chief Executive Officer	Jun 22 '23	Buy	2.31	40,000	92,400	784,359	Jun 22 04:01 PM
WADE JEFFREY L	President and CFO	Jun 20 '23	Buy	2.33	12,000	28,000	254,341	Jun 20 04:10 PM
Artal International S.C.A.	Director	Jun 05 '23	Buy	2.60	27,775,050	72,215,130	78,634,381	Jun 05 04:46 PM
Swain Judith L	Director	May 21 '23	Option Exercise	0.00	9,302	0	40,332	May 22 04:07 PM
NIES ALAN S	Director	May 21 '23	Option Exercise	0.00	9,302	0	41,046	May 22 04:05 PM
DEBBANE RAYMOND	Director	May 21 '23	Option Exercise	0.00	9,302	0	340,847	May 22 04:03 PM
LEFKOWITZ ROBERT J MD	Director	May 21 '23	Option Exercise	0.00	9,302	0	40,332	May 22 04:04 PM
Palantoni Frank	Director	May 21 '23	Option Exercise	0.00	9,302	0	40,332	May 22 04:06 PM
SOBECKI CHRISTOPHER J	Director	May 21 '23	Option Exercise	0.00	9,302	0	159,023	May 22 04:06 PM
Amouyal Philippe	Director	May 21 '23	Option Exercise	0.00	9,302	0	40,332	May 22 04:01 PM
BARKER SAM L	Director	May 21 '23	Option Exercise	0.00	9,302	0	79,617	May 22 04:02 PM

Open in Screener

PZZA

Papa John's International, Inc.

Apr 18 • 04:00PM ET

61.35

Dollar change +0.40
Percentage change 0.66	%

Consumer Cyclical • Restaurants • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

PZZA Papa John's International, Inc. daily Stock Chart

Held by: IJR VTI VB IWM VXF VBK IWO IJS SCHA IJT

Index	RUT	P/E	24.79	EPS (ttm)	2.47	Insider Own	1.40%	Shs Outstand	32.49M	Perf Week	-2.40%
Market Cap	2.01B	Forward P/E	19.65	EPS next Y	3.12	Insider Trans	-0.63%	Shs Float	32.31M	Perf Month	-14.66%
Income	82.10M	PEG	2.09	EPS next Q	0.58	Inst Own	114.26%	Short Float	7.66%	Perf Quarter	-18.53%
Sales	2.14B	P/S	0.94	EPS this Y	-2.73%	Inst Trans	-4.18%	Short Ratio	3.18	Perf Half Y	-8.85%
Book/sh	-14.13	P/B	-	EPS next Y	18.47%	ROA	8.62%	Short Interest	2.47M	Perf Year	-20.73%
Cash/sh	1.24	P/C	49.53	EPS next 5Y	11.88%	ROE	-	52W Range	60.66 - 86.38	Perf YTD	-19.52%
Dividend Est.	1.89 (3.08%)	P/FCF	17.27	EPS past 5Y	100.40%	ROI	17.34%	52W High	-28.97%	Beta	1.16
Dividend TTM	1.80 (2.93%)	Quick Ratio	0.64	Sales past 5Y	5.33%	Gross Margin	16.74%	52W Low	1.14%	ATR (14)	1.75
Dividend Ex-Date	Feb 09, 2024	Current Ratio	0.76	EPS Y/Y TTM	31.16%	Oper. Margin	6.89%	RSI (14)	31.03	Volatility	2.10% 2.70%
Employees	13200	Debt/Eq	-	Sales Y/Y TTM	1.60%	Profit Margin	3.84%	Recom	2.11	Target Price	80.08
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	20.21%	Payout	71.09%	Rel Volume	1.03	Prev Close	60.95
Sales Surprise	-1.18%	EPS Surprise	25.92%	Sales Q/Q	8.57%	Earnings	May 09 BMO	Avg Volume	778.54K	Price	61.35
SMA20	-5.60%	SMA50	-11.08%	SMA200	-14.72%	Trades		Volume	798,342	Change	0.66%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-12-24	Resumed	Stephens	Overweight	$75
Mar-22-24	Downgrade	BTIG Research	Buy → Neutral
Jan-05-24	Downgrade	Oppenheimer	Outperform → Perform
Jan-04-24	Downgrade	Stifel	Hold → Sell	$65
Nov-03-23	Downgrade	Stifel	Buy → Hold	$81 → $65
Oct-26-23	Downgrade	Wedbush	Outperform → Neutral	$95
Oct-19-23	Initiated	Deutsche Bank	Hold	$71
Sep-01-23	Upgrade	Wedbush	Neutral → Outperform	$80 → $95
Jun-14-23	Initiated	Piper Sandler	Neutral	$77
Jan-25-23	Initiated	BofA Securities	Buy	$103
Dec-21-22	Downgrade	Wedbush	Outperform → Neutral
Nov-07-22	Downgrade	Northcoast	Buy → Neutral
Sep-23-22	Initiated	Stephens	Overweight	$100
Feb-02-22	Upgrade	Northcoast	Neutral → Buy	$147
Nov-12-21	Initiated	The Benchmark Company	Buy	$145
Nov-05-21	Downgrade	Northcoast	Buy → Neutral	$136
Nov-05-21	Downgrade	Deutsche Bank	Buy → Hold	$127 → $136
Oct-06-21	Initiated	Loop Capital	Buy	$147
Aug-06-21	Reiterated	UBS	Neutral	$114 → $121
Aug-06-21	Reiterated	Stifel	Buy	$125 → $140

Show Previous Ratings

Apr-10-24 10:51AM	Papa John's (PZZA) and The Bajco Group Expand Partnership (Zacks)
Apr-09-24 08:00AM	Papa Johns Deepens Strategic Partnership With the Bajco Group to Expand Presence in North America With 50 New Stores by 2028 (Business Wire)
05:00AM	Q4 Earnings Highs And Lows: Papa John's (NASDAQ:PZZA) Vs The Rest Of The Traditional Fast Food Stocks (StockStory)
Apr-02-24 10:04AM	Papa Johns Unveils New Brand Platform Honoring Pizza Fans Unmatched Devotion (Business Wire)
07:30AM	Papa Johns Launches Crispy Cuppy 'Roni Platform featuring Premium Cupping Pepperoni across Menu Favourites (GlobeNewswire)
05:13AM	Loading…
05:13AM	How Papa Johns new brand platform connects pizza to marketing transformation (Marketing Dive)
Apr-01-24 07:00AM	Papa Johns to Report 2024 First Quarter Results on May 9, 2024 (Business Wire)
Mar-27-24 08:20AM	Analysts on Wall Street Lower Ratings for These 10 Stocks (Insider Monkey)
Mar-25-24 09:00AM	Papa Johns Launches Crispy Cuppy Roni Platform Featuring Premium Cupping Pepperoni Across Menu Favorites (Business Wire)
Mar-22-24 04:18PM	BTIG downgrades Papa John's stock on CEO departure (Yahoo Finance Video)
09:41AM	Best Buy upgraded, Nike downgraded: Wall Street's top analyst calls (The Fly)
Mar-21-24 03:54PM	Papa Johns CEO departs for Shake Shack; interim CEO named (Chain Store Age)
01:31PM	Shake Shack Turns to Papa John's Executive for New CEO; Stocks Fall (The Wall Street Journal)
08:50AM	Shake Shack names Papa John's chief as its CEO (Reuters)
07:41AM	Papa Johns Announces CEO Transition and Reaffirms Fiscal 2024 Adjusted Operating Income and Development Outlook (Business Wire)
09:47AM	Loading…
Mar-05-24 09:47AM	20 Countries with Most Cities Over 1 Million (Insider Monkey)
Mar-01-24 10:02AM	Papa John's International, Inc. (NASDAQ:PZZA) Q4 2023 Earnings Call Transcript (Insider Monkey)
09:37AM	Papa John's (PZZA) Q4 Earnings Beat Estimates, Revenues Lag (Zacks)
Feb-29-24 10:38PM	Q4 2023 Papa John's International Inc Earnings Call (Thomson Reuters StreetEvents)
01:55PM	Analyst Report: Papa John's International, Inc. (Morningstar Research)
12:28PM	Why Are Papa John's (PZZA) Shares Soaring Today (StockStory)
11:15AM	AMC, Duolingo, Papa John's: Trending Tickers (Yahoo Finance Video)
09:30AM	Papa John's (PZZA) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
08:10AM	Papa John's (PZZA) Tops Q4 Earnings Estimates (Zacks)
07:35AM	Papa John's International Inc (PZZA) Reports Record System-Wide Sales Despite International ... (GuruFocus.com)
07:25AM	Papa John's Q4 Profit Tops Estimates (RTT News)
07:20AM	Papa John's: Q4 Earnings Snapshot (Associated Press Finance)
07:16AM	Papa John's (NASDAQ:PZZA) Reports Sales Below Analyst Estimates In Q4 Earnings (StockStory)
07:00AM	Papa Johns Announces Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Feb-28-24 08:05AM	Due to Shaquille ONeals Business Commitments, Papa Johns Announces He Will Not Seek 2024 Board Re-Election (Business Wire)
02:01AM	Loading…
02:01AM	What To Expect From Papa John'ss (PZZA) Q4 Earnings (StockStory)
Feb-27-24 10:58AM	Papa John's (PZZA) to Report Q4 Earnings: What's in Store? (Zacks)
Feb-26-24 09:16AM	What Analyst Projections for Key Metrics Reveal About Papa John's (PZZA) Q4 Earnings (Zacks)
Feb-23-24 09:11AM	15 Highest Quality Pizza Chains in America (Insider Monkey)
Feb-16-24 01:04PM	Restaurant growth becoming more dependent on value offerings (Yahoo Finance Video)
Feb-09-24 05:12AM	Papa John's International Inc's Dividend Analysis (GuruFocus.com)
Feb-08-24 07:30AM	Papa Johns Raises $55,286 for Canadian Nonprofit (GlobeNewswire)
Jan-30-24 07:00AM	Papa Johns Declares Quarterly Dividend (Business Wire)
Jan-29-24 08:00AM	Papa Johns Announces Executive Transition (Business Wire)
Jan-25-24 12:16PM	Weight loss drugs may not have as much staying power in 2024 (Yahoo Finance Video)
12:14PM	Fast food chains are racing to build new franchises in the latest bid for growth (Yahoo Finance)
Jan-23-24 05:06AM	A Look Back at Traditional Fast Food Stocks' Q3 Earnings: Wendy's (NASDAQ:WEN) Vs The Rest Of The Pack (StockStory)
Jan-18-24 07:00AM	Papa Johns to Report 2023 Fourth Quarter and Full Year Financial Results on February 29, 2023 (Business Wire)
Jan-11-24 11:22PM	Analyst Report: Papa John's International, Inc. (Morningstar Research)
01:44PM	Papa John's, Domino's are vying for customers through innovation and value (Yahoo Finance)
04:08AM	A Look Back at Traditional Fast Food Stocks' Q3 Earnings: Yum! Brands (NYSE:YUM) Vs The Rest Of The Pack (StockStory)
Jan-10-24 07:36AM	Q3 Earnings Highlights: Papa John's (NASDAQ:PZZA) Vs The Rest Of The Traditional Fast Food Stocks (StockStory)
Jan-09-24 12:45PM	Papa John's (PZZA) Reports Q4 Business Update, Sales Rise Y/Y (Zacks)
Jan-08-24 07:00AM	Papa Johns Announces Back to Better 2.0 Ahead of 26th Annual ICR Conference, and Provides Preliminary 2023 Sales and Unit Development (Business Wire)
Jan-05-24 05:08PM	McDonald's, Papa John's downgraded on geopolitical headwinds (Yahoo Finance Video)
Jan-04-24 12:25PM	Yum Brands, Papa John's downgraded at Stifel (Yahoo Finance Video)
Jan-03-24 01:47PM	Papa John's (PZZA) Digital Efforts Strong, Macro Challenges Ail (Zacks)
07:30AM	Papa Johns Brings a New Deal Just to Canada (GlobeNewswire)
Dec-28-23 07:06PM	15 Best Franchises To Own in 2024 (Insider Monkey)
Dec-19-23 07:00AM	Papa Johns to Participate in the 2024 ICR Conference (Business Wire)
Dec-18-23 09:30AM	Papa Johns Introduces New Cheesy Calzone Epic Stuffed CrustThe "Stuff" That Holiday Dreams Are Made Of (Business Wire)
Dec-14-23 10:48AM	Here Comes Shaq-a-Claus (PR Newswire)
Dec-13-23 09:47AM	Papa Johns Celebrates the Holiday Season with 12 Days of Deals (Business Wire)
Dec-07-23 03:03PM	16 Best Franchises to Open With $10K in 2023 (Insider Monkey)
Dec-04-23 03:48AM	What Made Artisan Small Cap Fund to Sell Papa John's International (PZZA)? (Insider Monkey)
Nov-28-23 11:17AM	Here's Why You Should Retain Papa John's (PZZA) Stock Now (Zacks)
Nov-14-23 05:00AM	Why Papa Johns is returning to its 90s roots (Nation's Restaurant News)
Nov-12-23 11:19AM	20 Most Valuable Fast Food Companies in the World (Insider Monkey)
Nov-07-23 11:49AM	Analyst Report: Papa John's International, Inc. (Morningstar Research)
Nov-03-23 11:30AM	Papa Johns International, Inc. (NASDAQ:PZZA) Q3 2023 Earnings Call Transcript (Insider Monkey) +8.01%
11:08AM	Papa John's (PZZA) Q3 Earnings Beat Estimates, Revenues Lag (Zacks)
Nov-02-23 04:06PM	Analyst Report: Papa John's International, Inc. (Morningstar Research)
12:41PM	Wendy's & Shake Shack earnings: U.S. consumer in focus (Yahoo Finance Video)
11:30AM	Papa John's (PZZA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
09:31AM	Papa John's International Inc (PZZA) Reports 2% Revenue Growth in Q3 2023 (GuruFocus.com)
07:20AM	Papa John's (NASDAQ:PZZA) Misses Q3 Revenue Estimates (StockStory)
07:20AM	Papa John's: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	Papa Johns Announces Third Quarter 2023 Financial Results (Business Wire)
Nov-01-23 09:00AM	The Papa Johns Foundation Awards Nearly $1.4 Million in Grants to 270 Nonprofit Organizations to Build the Leaders of Tomorrow, Fight Hunger and Reduce Food Waste (Business Wire)
03:05AM	What To Expect From Papa John'ss (PZZA) Q3 Earnings (StockStory)
Oct-27-23 10:00AM	Bloomin' Brands (BLMN) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Oct-26-23 01:05PM	Papa Johns to retain ownership of Greater Louisville campus (American City Business Journals)
10:02AM	Papa John's (PZZA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-25-23 07:30AM	Papa Johns Looks to Help Relieve Hunger Through Sales of Its Shaq-a-Roni Pizza (GlobeNewswire)
Oct-24-23 04:30PM	Papa Johns Declares Quarterly Dividend (Business Wire)
04:30PM	Papa Johns Appoints John Garratt and Stephen Gibbs to the Board to Support Companys Long Term Growth Plan and Strengthen Leadership in Pizza Category (Business Wire)
09:00AM	Papa Johns Looks to Fuel Youth Entrepreneurs Through Sales of Its Shaq-a-Roni Pizza (Business Wire)
Oct-23-23 07:30AM	Papa Johns Jack-O'-Lantern Pizza Returns (GlobeNewswire)
Oct-05-23 04:37PM	Analyst Report: Papa John's International, Inc. (Morningstar Research)
Sep-27-23 12:05PM	Expansion Efforts Aid Papa John's (PZZA), Dismal Comps Hurt (Zacks)
07:30AM	Papa Johns to Report 2023 Third Quarter Results on November 2, 2023 (Business Wire)
Sep-13-23 08:00AM	Papa Johns Announces Executive Appointments (Business Wire)
Sep-07-23 07:34PM	Unveiling Papa John's International (PZZA)'s Value: Is It Really Priced Right? A Comprehensive Guide (GuruFocus.com)
Sep-01-23 06:51PM	Blackstone and Airbnb Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600 (PR Newswire)
10:00AM	MercadoLibre upgraded, PagerDuty downgraded: Wall Street's top analyst calls (The Fly)
Aug-29-23 12:07PM	Long Term Returns of Jeff Smiths Activist Targets (Insider Monkey)
Aug-23-23 03:34PM	These Are the ONLY 7 Restaurant Stocks to Consider in August 2023 (InvestorPlace)
Aug-22-23 07:30AM	Papa Johns Canada Fuels Fandom with New Garlic Epic Stuffed Crust Pizza (GlobeNewswire)
Aug-17-23 09:44AM	Here's Why You Should Retain Papa John's (PZZA) Stock Now (Zacks)
Aug-15-23 04:39PM	Analyst Report: Papa John's International, Inc. (Morningstar Research)
Aug-09-23 02:28PM	John Schnatter case will go to trial (American City Business Journals)
09:07AM	Papa John's International's (NASDAQ:PZZA) Upcoming Dividend Will Be Larger Than Last Year's (Simply Wall St.)
Aug-06-23 08:10AM	Do These 3 Checks Before Buying Papa John's International, Inc. (NASDAQ:PZZA) For Its Upcoming Dividend (Simply Wall St.)
Aug-05-23 02:52PM	Papa John's CEO unfazed by Dominos-Uber deal: The more the merrier (Yahoo Finance)
Aug-04-23 06:02PM	Papa Johns International, Inc. (NASDAQ:PZZA) Q2 2023 Earnings Call Transcript (Insider Monkey)

Papa John's International, Inc. engages in the operation and franchise of pizza delivery and carryout restaurants. It operates through the following segments: Domestic Company-owned Restaurants, North America Franchising, North America Commissaries, International Operations, and All Others. The Domestic Company-Owned Restaurants segment consists of retail sales of pizza and side items, breadsticks, cheese sticks, chicken poppers and wings, dessert items, and canned and bottled beverages. The North America Franchising segment involves the offering of sales and support activities, development rights, and collection of royalties from franchisees located in the United States and Canada. The North America Commissaries segment includes the eleven full-service regional dough production and distribution and quality control centers. The International Operations segment represents all restaurant operations outside of the United States and Canada. The All Others segment focuses on franchise contributions to marketing funds and sale, company-owned and franchised restaurants, information systems and related services used in restaurant operations, point-of-sale system, online and other technology-based ordering platforms, printing, and promotional items. The company was founded by John H. Schnatter in 1984 and is headquartered in Louisville, KY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
KOELLNER LAURETTE T	Director	Mar 07 '24	Option Exercise	41.15	2,886	118,759	21,690	Mar 07 05:49 PM
KOELLNER LAURETTE T	Director	Mar 07 '24	Sale	70.21	2,886	202,625	18,804	Mar 07 05:49 PM
Coleman Christopher L.	Director	Feb 15 '24	Option Exercise	50.59	3,708	187,588	28,407	Feb 16 05:12 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

LXRX

Lexicon Pharmaceuticals Inc

PZZA

Papa John's International, Inc.

Upgrade your FINVIZ experience